Patients living with diabetes who use continuous glucose monitoring devices had 35% lower total cost of care and 23% higher device adherence when therapy was provided through a medical vs. pharmacy be ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...
There are currently four bills under consideration that would have a direct or indirect impact on PBMs, as well as health ...
If a patient receives a continuous glucose monitor device through their medical benefit, they may be more adherent and may ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The owner of one of the three largest pharmacy middlemen in the United States on Tuesday filed suit to quash an attempt by ...
On June 17, 2024, the final rule for Medicare Part D introduced new health IT standards, mandating the adoption of NCPDP ...
The Arkansas Insurance Department will require pharmacy benefit managers (PBMs) to include dispensing fees in their ...
Cigna Healthcare's divestiture of low-margin Medicare businesses will allow focus on employer-sponsored plans. Learn more on ...
The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback